november AG

euro adhoc: november AG
Financial Figures/Balance Sheet
november AG obliged to carry out comprehensive value adjustments in its balance sheet

@@start.t1@@--------------------------------------------------------------------------------   Disclosure announcement transmitted by euro adhoc. The issuer is responsible   for the content of this announcement. --------------------------------------------------------------------------------@@end@@

09.11.2006

Because of the insolvency filings of the parent and the two subsidiaries identif GmbH and directif GmbH, a record loss is being shown.

Erlangen, 9 November 2006. In the first 9 months of the year 2006, group operating loss of Erlangen based development and holding company november AG (ISIN DE0006762909) has increased by 332% to -6.980 Mio. EUR compared to the same period last year.  Although group turn-over increased to 5.797 Mio. EUR, thus exceeding turnover in the same period last year (4.860 Mio. EUR) by 19%, consolidated loss for the period of 1 January 2006 to 30 September 2006 increased to -24.409 Mio. EUR (PY: -0.836 Mio. EUR), in particular through value adjustments necessary in the course of the insolvency filings. As per the end of the first 9 months, november AG’s total liquidity amounts to 1.215 Mio. EUR. Consolidated balance sheet total as per the end of the third quarter is in the amount of 4.303 Mio. EUR (31 December 2005: 26.492 Mio. EUR). Earnings per share (EPS) reduced to EUR -3.25. For the period of 1 January 2006 to 30 September 2006, on average the fully consolidated group enterprises of november group employed 65 full-time employees in total.

@@start.t2@@end of announcement                                                 euro adhoc 09.11.2006 08:36:32
--------------------------------------------------------------------------------@@end@@

ots Originaltext: november AG
Im Internet recherchierbar: http://www.presseportal.ch

Further inquiry note:
Marcus Weichert
Leitung PR/IR
Telefon: +49(0)9131 75088 868
E-Mail: weichert@november.de

Branche: Biotechnology
ISIN:      DE0006762909
WKN:        676290
Index:    CDAX, Technologie All Share, Prime All Share
Börsen:  Frankfurter Wertpapierbörse / regulated dealing/prime
              standard
              Börse Berlin-Bremen / free trade
              Baden-Württembergische Wertpapierbörse / free trade
              Börse Düsseldorf / free trade
              Niedersächsische Börse zu Hannover / free trade
              Bayerische Börse / free trade



Weitere Meldungen: november AG

Das könnte Sie auch interessieren: